Cergentis
After receiving her Masters degree in cancer genomics and developmental biology from the Utrecht University, Vera attended a PhD program at the NKI. During her PhD she focused on the role of DNA repair mechanisms in telomere dysfuncion. She identified a new factor involved in DNA repair of double strand breaks which led to a publication in Nature.
At Cergentis Vera is working as a product developer on the optimisation of the TLA technology for oncogenetic applications.
This person is not in any offices
Cergentis
1 followers
Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.